227 related articles for article (PubMed ID: 7416233)
1. Lysophosphatidic acids: III. Enhancement of neutrophil chemotaxis.
Gerrard JM; Clawson CC; White JG
Am J Pathol; 1980 Sep; 100(3):609-18. PubMed ID: 7416233
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine.
Patrone F; Dallegri F; Sacchetti C
Res Exp Med (Berl); 1980; 177(1):19-22. PubMed ID: 7403684
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil bipolar shape formation in whole blood. A simple and rapid method for the assessment of neutrophil leukocyte responsiveness.
Jadwin DF; Smith CW; Meadows TR
Am J Clin Pathol; 1981 Oct; 76(4):395-402. PubMed ID: 6794351
[TBL] [Abstract][Full Text] [Related]
4. Chemotactic factor-induced effects upon deformability of human polymorphonuclear leukocytes.
Kawaoka EJ; Miller ME; Cheung AT
J Clin Immunol; 1981 Jan; 1(1):41-4. PubMed ID: 7334069
[TBL] [Abstract][Full Text] [Related]
5. Local anesthetics attenuate lysophosphatidic acid-induced priming in human neutrophils.
Fischer LG; Bremer M; Coleman EJ; Conrad B; Krumm B; Gross A; Hollmann MW; Mandell G; Durieux ME
Anesth Analg; 2001 Apr; 92(4):1041-7. PubMed ID: 11273947
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
Harvath L; Yancey KB; Katz SI
J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
[TBL] [Abstract][Full Text] [Related]
7. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
Marasco WA; Becker EL; Oliver JM
Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
[TBL] [Abstract][Full Text] [Related]
8. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
[TBL] [Abstract][Full Text] [Related]
10. Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
Dahinden C; Fehr J
J Clin Invest; 1980 Nov; 66(5):884-91. PubMed ID: 7430350
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of calcium-dependent chemotactic factor activatable esterase activity in human neutrophils: relationship with chemotaxis and chemotactic deactivation.
Mehta J; Mandell B; Kleyman T; Spilberg I
Inflammation; 1981 Jun; 5(2):89-101. PubMed ID: 7275278
[TBL] [Abstract][Full Text] [Related]
12. Leucoattractants enhance complement receptors on human phagocytic cells.
Kay AB; Glass EJ; Salter DM
Clin Exp Immunol; 1979 Nov; 38(2):294-9. PubMed ID: 527263
[TBL] [Abstract][Full Text] [Related]
13. Effects of human complement component 1 inactivator on neutrophil chemotaxis and chemotactic deactivation.
Patrick RA; Hollers JC; Liu DY; Giese BH; Smith CW
Infect Immun; 1980 Jun; 28(3):700-7. PubMed ID: 7399690
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidic acid elicits calcium mobilization and actin polymerization through a tyrosine kinase-dependent process in human neutrophils: a mechanism for induction of chemotaxis.
Siddiqui RA; English D
Biochim Biophys Acta; 1997 Nov; 1349(1):81-95. PubMed ID: 9421199
[TBL] [Abstract][Full Text] [Related]
15. Unconjugated bile acids modulate adult and neonatal neutrophil chemotaxis induced in vitro by N-formyl-met-leu-phe-peptide.
Santoro P; Raimondi F; Annunziata S; Paludetto R; Annella T; Ciccimarra F
Pediatr Res; 2002 Mar; 51(3):392-6. PubMed ID: 11861947
[TBL] [Abstract][Full Text] [Related]
16. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
Keller HU; Wissler JH; Damerau B
Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
[TBL] [Abstract][Full Text] [Related]
17. Chemotactic deactivation of human neutrophils: evidence for nonspecific and specific components.
Nelson RD; McCormack RT; Fiegel VD; Simmons RL
Infect Immun; 1978 Nov; 22(2):441-4. PubMed ID: 730365
[TBL] [Abstract][Full Text] [Related]
18. Defective neutrophil chemotaxis resulting from thermal injury: restoration of directed migration by increasing Boyden chamber filter pore size.
Stein MD; Stevens JM; Herndon DN
Clin Immunol Immunopathol; 1983 May; 27(2):234-9. PubMed ID: 6872354
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of synthetic chemotactic peptides on neutrophil function.
Patrone F; Dallegri F; Bonvini E; Sacchetti C
Int Arch Allergy Appl Immunol; 1980; 62(3):316-23. PubMed ID: 7390636
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of chemotactic migration by the local anesthetic tetracaine.
Kownatzki E; Uhrich S
Immunobiology; 1983 Jul; 165(1):97-106. PubMed ID: 6885104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
